Close Menu

Thomas Goetz, a journalist who's responsible for the Epidemix blog, has a post on personalized medicine. The theme: waaay back in the day -- before diseases were well understood -- patients were treated on an individual basis. Goetz says the concept of personalized medicine, in a funny way, is moving us back to that kind of mentality. He predicts that the cycle will continue as individually tailored medicine becomes more large-scale with advances like the HapMap and other population-based approaches.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.